Testicular Cancer

EA 3.2 Testicular Cancer

Testicular cancer is a type of cancer that develops in the cells of the testicles, which are the male reproductive glands that produce sperm and hormones. It is a relatively rare form of cancer, but it is the most common cancer in young people with testicles aged 15 to 35 years. The exact cause of testicular cancer is unknown, but certain risk factors have been identified, including having a family history of the disease, having an undescended testicle, having a personal history of testicular cancer, and having abnormal testicular development. Symptoms of testicular cancer may include a lump or swelling in one or both testicles, pain or discomfort in the testicles or scrotum, a feeling of heaviness in the scrotum, and enlargement or tenderness of the breasts. Testicular cancer is usually diagnosed through a physical exam, imaging tests such as ultrasound, and blood tests to check for tumour markers. Treatment for testicular cancer typically involves surgery to remove the affected testicle, followed by radiation therapy, chemotherapy, or a combination of these, depending on the stage and type of cancer.

Expertise Area Coordinator and Vice-EAC

Expertise Area Coordinator: Yue Che

Yue Che is a clinical scientist and urologist at the Department of Urology, Heinrich-Heine-University Düsseldorf, Germany, specializing in open and robotic retroperitoneal surgery focusing on testicular cancer.

He received his medical degree from the University of Freiburg and began his surgical residency at the Porz am Rhein Hospital in 2012. In 2015, he successfully defended his PhD thesis, “The functional integration of voxel-based morphometric changes after mirror therapy.” From 2015 to 2018, he completed his urology residency at the Heilig Geist Hospital in Cologne, Germany. Afterwards, Dr Che started as a urologist at the University Hospital of Düsseldorf and was appointed senior physician in 2020.

Since 2019, he has been a member of the clinical research team for testicular cancer in Düsseldorf and has been appointed head of this team in 2022.

Vice-EAC: Tomas Buchler

Conditions and Codes

  • Tumour of testis and paratestis: ORPHAcode 363472 / ICD-10 Code C62

Healthcare Providers

BE Leuven UZ, CZ Prague Thomayer, DE Düsseldorf UK, DE Hamburg-Eppendorf UK, ES Barcelona Fundació Puigvert, ES Santander Valdecilla, HR Zagreb KBC, IT Padua AOU, LT Vilnius SK, NL Rotterdam Erasmus, NL Amsterdam AvL, NL Utrecht UMC, PT Porto IPO

Patient Information

Testicular Cancer Patient Information (in collaboration with the EAU and Orchid)

Additional Resources